- Home
- AAME vs LGVN Comparison
AAME vs LGVN Comparison
Compare AAME & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAME
- LGVN
- Stock Information
- Founded
- AAME 1968
- LGVN 2014
- Country
- AAME United States
- LGVN United States
- Employees
- AAME N/A
- LGVN N/A
- Industry
- AAME Life Insurance
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- AAME Finance
- LGVN Health Care
- Exchange
- AAME Nasdaq
- LGVN Nasdaq
- Market Cap
- AAME 46.3M
- LGVN 23.4M
- IPO Year
- AAME N/A
- LGVN 2021
- Fundamental
- Price
- AAME $1.95
- LGVN $1.47
- Analyst Decision
- AAME
- LGVN Strong Buy
- Analyst Count
- AAME 0
- LGVN 3
- Target Price
- AAME N/A
- LGVN $8.67
- AVG Volume (30 Days)
- AAME 27.1K
- LGVN 715.2K
- Earning Date
- AAME 08-13-2025
- LGVN 08-13-2025
- Dividend Yield
- AAME 0.99%
- LGVN N/A
- EPS Growth
- AAME N/A
- LGVN N/A
- EPS
- AAME N/A
- LGVN N/A
- Revenue
- AAME $191,355,000.00
- LGVN $2,225,000.00
- Revenue This Year
- AAME N/A
- LGVN N/A
- Revenue Next Year
- AAME N/A
- LGVN $51.48
- P/E Ratio
- AAME N/A
- LGVN N/A
- Revenue Growth
- AAME 2.04
- LGVN 127.50
- 52 Week Low
- AAME $1.25
- LGVN $1.14
- 52 Week High
- AAME $2.61
- LGVN $4.88
- Technical
- Relative Strength Index (RSI)
- AAME 45.39
- LGVN 57.16
- Support Level
- AAME $1.94
- LGVN $1.37
- Resistance Level
- AAME $2.61
- LGVN $1.40
- Average True Range (ATR)
- AAME 0.16
- LGVN 0.12
- MACD
- AAME -0.04
- LGVN 0.02
- Stochastic Oscillator
- AAME 4.35
- LGVN 47.70
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.